catalog number :
MBS1004138
products type :
Recombinant Protein
products full name :
Recombinant Mouse Interferon alpha/beta receptor 2
products short name :
Interferon alpha/beta receptor 2
products name syn :
Type I interferon receptor 2
other names :
interferon alpha/beta receptor 2 isoform b; Interferon alpha/beta receptor 2; interferon alpha/beta receptor 2; interferon (alpha and beta) receptor 2; Type I interferon receptor 2
products gene name :
Ifnar2
other gene names :
Ifnar2; Ifnar2; Ifnar-2; AI747302; IFN-R-2; IFN-alpha/beta receptor 2
uniprot entry name :
INAR2_MOUSE
host :
E Coli or Yeast or Baculovirus or Mammalian Cell
sequence positions :
22-242
sequence :
SLETITPSAFDGYPDEPCTINITIRNSRLILSWELENKS
GPPANYTLWYTVMSKDENLTKVKNCSDTTKSSCDVTDKW
LEGMESYVVAIVIVHRGDLTVCRCSDYIVPANAPLEPPE
FEIVGFTDHINVTMEFPPVTSKIIQEKMKTTPFVIKEQI
GDSVRKKHEPKVNNVTGNFTFVLRDLLPKTNYCVSLYFD
DDPAIKSPLKCIVLQPGQESGLSESA
purity :
Greater than 90% as determined by SDS-PAGE.
form :
Liquid containing glycerol; lyophilization may be available upon request.
storage stability :
Store at -20 degree C, for extended storage, conserve at -20 degree C or -80 degree C.
products description :
Associates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation. Isoform 1 and isoform 2 are directly involved in signal transduction due to their association with the TYR kinase, JAK1. Isoform 2 and 3 may be potent inhibitors of type I IFN receptor activity.
products references :
Mammalian type I interferon receptors consists of two subunits
IFNaR1 and IFNaR2.Kim S.H., Cohen B., Novick D., Rubinstein M.Gene 196:279-286(1997)
Cloning and characterization of soluble and transmembrane isoforms of a novel component of the murine type I interferon receptor, IFNAR 2.Owczarek C.M., Hwang S.Y., Holland K.A., Gulluyan L.M., Tavaria M., Weaver B., Reich N.C., Kola I., Hertzog P.J.J. Biol. Chem. 272:23865-23870(1997)
Multiple regions within the promoter of the murine Ifnar-2 gene confer basal and inducible expression.Hardy M.P., Hertzog P.J., Owczarek C.M.Biochem. J. 365:355-367(2002)
Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.
Proteome-wide characterization of N-glycosylation events by diagonal chromatography.Ghesquiere B., Van Damme J., Martens L., Vandekerckhove J., Gevaert K.J. Proteome Res. 5:2438-2447(2006)
The phagosomal proteome in interferon-gamma-activated macrophages.Trost M., English L., Lemieux S., Courcelles M., Desjardins M., Thibault P.Immunity 30:143-154(2009)
ncbi acc num :
NP_001103968.1
ncbi gb acc num :
NM_001110498.1
ncbi mol weight :
26.76kD
ncbi pathways :
Cytokine Signaling In Immune System Pathway (1323763); Cytokine-cytokine Receptor Interaction Pathway (83248); Cytokine-cytokine Receptor Interaction Pathway (460); Hepatitis C Pathway (173974); Hepatitis C Pathway (173907); Herpes Simplex Infection Pathway (377874); Herpes Simplex Infection Pathway (377865); Immune System Pathway (1323639); Influenza A Pathway (217174); Influenza A Pathway (217150)
uniprot summary :
IFNAR2: Associates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation. Isoform 1 and isoform 2 are directly involved in signal transduction due to their association with the TYR kinase, JAK1. Isoform 3 is a potent inhibitor of type I IFN receptor activity. Belongs to the type II cytokine receptor family. 3 isoforms of the human protein are produced by alternative splicing. Protein type: Receptor, cytokine; Membrane protein, integral. Cellular Component: extracellular region; extracellular space; integral to membrane; integral to plasma membrane; membrane; plasma membrane. Molecular Function: interferon-alpha/beta binding; interferon-alpha/beta receptor activity; interleukin-20 binding; protein kinase binding. Biological Process: cell proliferation; regulation of transcription from RNA polymerase II promoter
size4 :
0.05 mg (Baculovirus)